Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions

NCT01073137 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2010-02-23

No results posted yet for this study

Summary

The purpose of the research is to determine whether a noninvasive hearing test may be used to predict blood glucose in people with diabetes.

Conditions

Sponsors & Collaborators

  • Portland VA Medical Center

    lead FED

Principal Investigators

  • Eric A Wan, PhD · Oregon Health and Science University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073137 on ClinicalTrials.gov